Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| BLUE BIOFUELS, INC.BIOF · Entity 2467 | Director · Chief Executive Officer · 10% owner | December 31, 2024 | December 31, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
BLUE BIOFUELS, INC.
Report date December 31, 2024 · Filed December 31, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Call OptionSEC Table II · derivative / convertible security · Conversion / exercise price $0.12 · Expires 2029-12-11 | Direct | 12,266,446 |
Reported balance
After 2024-12-31 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2024-12-31 · Grant · Acquired 826,446 · Balance 12,266,446 |
| Call OptionSEC Table II · derivative / convertible security · Conversion / exercise price $0.12 · Expires 2029-12-11 | Direct | 13,092,892 |
Reported balance
After 2024-12-31 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2024-12-31 · Grant · Acquired 826,446 · Balance 13,092,892 |
| Call OptionSEC Table II · derivative / convertible security · Conversion / exercise price $0.11 · Expires 2034-12-11 | Direct | 15,266,446 |
Reported balance
After 2024-12-31 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2024-12-31 · Grant · Acquired 2,173,554 · Balance 15,266,446 |
| Call OptionSEC Table II · derivative / convertible security · Conversion / exercise price $0.11 · Expires 2034-12-11 | Direct | 17,440,000 |
Reported balance
After 2024-12-31 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2024-12-31 · Grant · Acquired 2,173,554 · Balance 17,440,000 |
| Call OptionSEC Table II · derivative / convertible security · Conversion / exercise price $0.11 · Expires 2034-12-11 | Direct | 21,933,450 |
Reported balance
After 2024-12-31 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2024-12-31 · Grant · Acquired 4,493,450 · Balance 21,933,450 F1: The options above with an unknown exercisable date vest upon the sooner of revenue from the production of biofuels or the uplisting to a major exchange. |
Filing footnotes · ownership attribution and instrument terms
F1: The options above with an unknown exercisable date vest upon the sooner of revenue from the production of biofuels or the uplisting to a major exchange.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 31, 2024 Filed Dec 31, 2024 20:42 UTC | BLUE BIOFUELS, INC. BIOF · Entity 2467 | GrantCall Option · Derivative | 4,493,450 | $0.00 Strike: $0.11 | $0.00 |
DisclosureSEC source: 0001493152-24-052687 · ownership.xml · derivative · entry 5 Slager Benjamin · CIK 0001844165 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,933,450 Underlying: Stock · 4,493,450 shares Expires 2034-12-11 F1 · derivative.exercise_date: The options above with an unknown exercisable date vest upon the sooner of revenue from the production of biofuels or the uplisting to a major exchange. Read SEC document |
| December 31, 2024 Filed Dec 31, 2024 20:42 UTC | BLUE BIOFUELS, INC. BIOF · Entity 2467 | GrantCall Option · Derivative | 2,173,554 | $0.00 Strike: $0.11 | $0.00 |
DisclosureSEC source: 0001493152-24-052687 · ownership.xml · derivative · entry 4 Slager Benjamin · CIK 0001844165 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,440,000 Underlying: Stock · 2,173,554 shares Expires 2034-12-11 Read SEC document |
| December 31, 2024 Filed Dec 31, 2024 20:42 UTC | BLUE BIOFUELS, INC. BIOF · Entity 2467 | GrantCall Option · Derivative | 2,173,554 | $0.00 Strike: $0.11 | $0.00 |
DisclosureSEC source: 0001493152-24-052687 · ownership.xml · derivative · entry 3 Slager Benjamin · CIK 0001844165 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,266,446 Underlying: Stock · 2,173,554 shares Expires 2034-12-11 Read SEC document |
| December 31, 2024 Filed Dec 31, 2024 20:42 UTC | BLUE BIOFUELS, INC. BIOF · Entity 2467 | GrantCall Option · Derivative | 826,446 | $0.00 Strike: $0.12 | $0.00 |
DisclosureSEC source: 0001493152-24-052687 · ownership.xml · derivative · entry 2 Slager Benjamin · CIK 0001844165 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,092,892 Underlying: Stock · 826,446 shares Expires 2029-12-11 Read SEC document |
| December 31, 2024 Filed Dec 31, 2024 20:42 UTC | BLUE BIOFUELS, INC. BIOF · Entity 2467 | GrantCall Option · Derivative | 826,446 | $0.00 Strike: $0.12 | $0.00 |
DisclosureSEC source: 0001493152-24-052687 · ownership.xml · derivative · entry 1 Slager Benjamin · CIK 0001844165 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,266,446 Underlying: Stock · 826,446 shares Expires 2029-12-11 Read SEC document |
| May 22, 2022 Filed Jun 3, 2022 17:35 UTC | BLUE BIOFUELS, INC. BIOF · Entity 2467 | GiftCommon | 360,000 | $0.17 | $61,200.00 |
DisclosureSEC source: 0001493152-22-015793 · ownership.xml · nonDerivative · entry 1 Slager Benjamin · CIK 0001844165 · Director · CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,140,000 Read SEC document |
| April 27, 2022 Filed May 2, 2022 19:47 UTC | BLUE BIOFUELS, INC. BIOF · Entity 2467 | PurchaseWarrants · Derivative | 500,000 | $0.15 Strike: $0.25 | $75,000.00 |
DisclosureSEC source: 0001493152-22-011775 · ownership.xml · derivative · entry 3 Slager Benjamin · CIK 0001844165 · Director · CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,500,000 Underlying: Common · 500,000 shares Expires 2027-04-27 Read SEC document |
| April 27, 2022 Filed May 2, 2022 19:47 UTC | BLUE BIOFUELS, INC. BIOF · Entity 2467 | PurchaseCommon Stock | 500,000 | $0.15 | $75,000.00 |
DisclosureSEC source: 0001493152-22-011775 · ownership.xml · nonDerivative · entry 1 Slager Benjamin · CIK 0001844165 · Director · CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,500,000 Read SEC document |
| December 13, 2021 Filed Feb 24, 2022 22:50 UTC | BLUE BIOFUELS, INC. BIOF · Entity 2467 | OtherCommon stock | 15,000,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-22-005438 · ownership.xml · nonDerivative · entry 2 Slager Benjamin · CIK 0001844165 · Director · CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Benjamin Slager 2021 irrevocable trust Disclosed balance after: 15,000,000 Read SEC document |
| December 13, 2021 Filed Feb 24, 2022 22:50 UTC | BLUE BIOFUELS, INC. BIOF · Entity 2467 | GiftCommon stock | 15,000,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-22-005438 · ownership.xml · nonDerivative · entry 1 Slager Benjamin · CIK 0001844165 · Director · CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000,000 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.